Church & Dwight

Church & Dwight's second-quarter organic sales jumped 5.8%, reflecting higher volumes (4.3%) and increased prices (1.5%). But commodity inflation, tariffs, higher transportation costs, and increased marketing spending resulted in a 220-basis-point erosion in the adjusted operating margin to 18.8%.

Why it matters: Amid a tough macro backdrop, Church's mix (heavily weighted to the value tier at 40% of sales) and a flurry of new offerings are hitting the mark with consumers. However, if the macroeconomic picture improves, we surmise it could again lose out to premium fare. Despite the inroads made of late, we posit that Church's inferior scale and negotiating power may open the door to depressed sales and margins over time, especially as switching costs in its categories are nonexistent.

The bottom line: We don't expect a material change to our $77 per share fair value estimate for no-moat Church after incorporating second-quarter marks and its slightly improved outlook for fiscal 2026 for organic sales up 4%-5% (from 3%-4%) and adjusted EPS growth of 6%-8% (from 5%-8%). Shares trade at nearly a 30% premium to our intrinsic valuation, so we think investors should remain on the sidelines. We forecast 3% average yearly sales growth through fiscal 2035, largely driven by increased volumes. But our outlook is a far cry from the annual 5%-plus growth seemingly implied by the current market price.

Between the lines: Church's thirst for deals has yet to be quenched. The firm acquired Miss Mouth's Messy Eater (which manufactures stain removers) for $325 million (12 times EBITDA) in June and continues to convey an appetite for tie-ups, particularly to extend its global reach. While expanded shelf placement can provide a jolt for added brands, this doesn't ensure staying power. We suspect this is proving the case for Touchland's more discretionary hand sanitizer line, as management refrained from disclosing performance after a first-quarter deceleration.

After taking into account Church's fiscal 2026 second-quarter results (6% organic sales growth and a 220-basis-point erosion in adjusted operating margins to 18.8%), revised fiscal 2026 outlook (4%-5% organic sales growth and 6%-8% growth in adjusted EPS), and time value, we're edging up our fair value estimate to $78 per share, from $77. We maintain our long-term outlook for 3%-4% sales growth and high-teens average operating margins over our 10-year explicit forecast. Our valuation implies a fiscal 2027 enterprise value/adjusted EBITDA of 14.

While the macro and competitive backdrop remain challenging, we expect products like laundry to remain in high demand as a focus on disinfecting and hygiene stays top of mind for consumers. However, we don't think the firm's growth runway is limitless. Winning internationally could prove a tough slog, given varying consumer preferences and regulatory backdrops around the world. This underpins our expectations for less than 5% average annual sales growth from the international business in the long term, despite its relatively nascent exposure.

Further, inflationary headwinds have yet to subside amid tariffs and the conflict in the Middle East. We think offsetting inflation with pricing is unlikely over the near term, as consumers could increasingly opt to trade down or out of the categories in which Church plays, given the financial strains they face. Despite these pressures, we think it will be crucial for Church to direct resources to support its brands, given intense competition. In our view, a lack of investment here inhibits its fare from standing out on the shelf. We don't anticipate competition will lessen as supply more closely matches demand, so we expect Church will step up its spending. We forecast it to allocate more than 11% of sales to marketing on average through fiscal 2035.

After multiple acquisitions over the past 20-plus years, Church & Dwight has evolved from a baking soda company to a sizable global household and personal care player. However, an economic moat has proven elusive, in our view, as the firm’s brands have failed to gain much clout with retailers or consumers. Returns on invested capital, including goodwill, look decent, averaging around 12% annually between fiscal 2021 and 2025. Still, we see material risk that returns could be capped beyond a 10-year horizon, especially considering its acquisitive nature. We believe Church’s hunger for growth could result in the accumulation of significant goodwill on the balance sheet (more than $2.6 billion at the end of 2025, up from $857 million at the end of 2010), weighing on returns. This trend has been evident over the past 10 years, during which ROICs, including goodwill, fell from 24% in 2011 to the low double digits more recently.

Moats in consumer packaged goods typically stem from intangible assets, such as strong brands and established relationships with retailers. A strong brand can also, at times, bolster a cost advantage. We don’t believe this has been the case for Church. Where Church maintains dominance (such as North American hair removal and bleach, with about 40% share), the category carries little weight with retailers or consumers, as annual industry sales amount to around $245 million, down from more than $254 million three years ago. In its larger, faster-growing segments, Church is dwarfed by other household and personal care behemoths. In North American laundry detergent (a category that generates more than $12.8 billion in retail sales), Church has carved out a 13% share, down from 14% in 2019 and significantly lagging the 62% that wide-moat Procter & Gamble boasts (up from 59%). Church has almost 18% share of the North American cat litter market, which accounts for approximately $5.8 billion in annual retail sales. However, that space is dominated by wide-moat Nestlé, which controls 35% of the category, and includes wide-moat Clorox (16% share), which also provides stiff competition.

Church’s lagging brand standing is also evident in the composition of its historical organic sales growth, which has tended to be driven by volume (up around 3% on average over the past 15 years). The company has failed to consistently pass inflationary pressures through to consumers, as prices have only provided a 1% benefit to its top line. Even in fiscal 2022, when prices rose 6.5%, volume fell 5.1%, supporting our view that the firm cannot raise prices without a corresponding decline in volume. We believe Church has attempted to counter this by expending a higher percentage of revenue on marketing (nearly 12% on average over fiscal 2015-25, compared with its wide-moat competitors, which average 10%). And we forecast its marketing spending will average more than 11% of sales annually through fiscal 2035. In our view, a higher percentage of revenue directed toward marketing (in hopes of gaining share) indicates a mix of weaker brands relative to competitors with leading products and greater pricing power.

In our view, this lack of pricing power is particularly challenging in a sector with intense competition and virtually nonexistent switching costs. Church is significantly smaller than its main competitors, suggesting it hasn't built much influence with retailers. Church had annual net sales of $6.2 billion in fiscal 2025, compared with P&G’s $87 billion and wide-moat Unilever’s $57 billion in the most recently completed fiscal year. Given this, Church lacks the negotiating power to influence retailers. This makes gaining shelf space more difficult, especially as 23% of Church’s revenue comes from wide-moat Walmart. Management has discussed the challenges faced in securing and maintaining shelf space (which is inherently limited in physical channels), particularly as retailers are more inclined to accommodate bigger brands with greater negotiating power and lower-priced private-label products, which are higher margin for retailers.

Church derives 35% of its sales from value-priced fare, but peers’ emphasis on innovation across price tiers is thwarting trade-down. We view the loss of share to other brands or consumers trading out of its categories as an imminent threat to Church.

To broaden its reach and given CEO Rick Dierker's hunger for growth, the company could pursue inorganic opportunities that take it beyond its areas of expertise. This may also stretch its financial and personnel resources. We’ve witnessed this in a few tie-ups over the past several years, which management ultimately shuttered—Spinbrush, Waterpik showerheads, and Flawless ($150 million in aggregate annual sales, or 2%-3% of its sales base). It also sold its vitamin, mineral, and supplement brands at the end of fiscal 2025. Overall, this penchant for deals dents our confidence in Church’s ability to consistently generate excess returns over the next decade, a requirement for assigning the firm a narrow moat rating.

In consumer products, cost advantages can accompany an intangible asset edge. While Church has historically generated excess returns, we attribute this to its asset-light model (it employs third-party manufacturers for around one-third of its production). This cannot be deemed a unique advantage, given others also have access to these suppliers. Further, Church’s manufacturing process is not differentiated or specialized, failing to evidence a cost edge. In specialty products, we believe Church realizes a slight benefit from its vertically integrated supply chain, which provides sourcing advantages. The bulk of its specialty products use baking soda as the main ingredient (for animal feed, industrial baking, and industrial cleaning). However, at less than 10% of sales, this segment does not affect our moat rating.

We think Church could boost sales by expanding the distribution of recently acquired TheraBreath mouthwash, Hero pimple patches, and Touchland hand sanitizers in the US and abroad.

With around 35% of its 2025 sales from value-priced goods, Church should be well-positioned to weather consumer spending headwinds.

Exiting production of lower-margin private-label products unlocks an opportunity to expand margins as the firm produces more of its own branded products where demand persists.

An intensifying promotional environment across the industry could ensue with the aim of boosting volumes, dampening sales and gross margins.

Beyond larger branded peers and lower-priced options, the increased penetration of social media and e-commerce has facilitated the rise of smaller niche upstart brands angling to eat into Church's market share.

The firm's acquisition track record is spotty. For one, its foray into vitamins, minerals, and supplements (since sold) saw it cede share over a multiyear horizon, resulting in an impairment charge of more than $350 million.